Thus, these studies have sparked renewed interest in the pathogenesis of T-ALL and greatly expanded the role of NOTCH1 in the etiology and molecular tumorigenesis of this human disease with the hope of finding novel targeted therapies that interfere with NOTCH signaling. Here, NOTCH1 is linked to acute lymphoblastic leukemia.